Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis

BACKGROUND: The treatment of tuberous sclerosis complex (TSC) using mammalian target of rapamycin (mTOR) inhibitors is clinically promising. The aim of the present study was to evaluate the efficacy and safety of mTOR inhibitors for improving the clinical symptoms of TSC. METHODS: We performed a sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Zhou, Ying, Chen, Chaoyang, Yang, Ting, Zhou, Shuang, Chen, Shuqing, Wu, Ye, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373010/
https://www.ncbi.nlm.nih.gov/pubmed/30760308
http://dx.doi.org/10.1186/s13023-019-1012-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373010/
https://www.ncbi.nlm.nih.gov/pubmed/30760308
http://dx.doi.org/10.1186/s13023-019-1012-x

Ejemplares similares